Your search for comorbidities returned 105 results

Use of angiotensin converting enzyme inhibitors or angiotensin receptor blockers was not found to be associated with greater odds of testing positive for COVID-19.

COVID-19was found to be associated with a higher fatality rate in recipients of heart transplant.

Children may experience acute cardiac decompensation due to a severe inflammatory state (multisystem inflammatory syndrome in children or MIS-C) following infection with SARS-CoV-2.

Researchers found that the drug regimens were associated with an increased risk of death even after accounting for factors such as age, race, BMI, and comorbidities.

The use of immune globulin therapy appears to benefit children who experience acute heart failure caused by coronavirus disease 2019 (COVID-19)-related multisystem inflammatory syndrome, according to the findings of a case series recently published in Circulation.

Patients treated with hydroxychloroquine alone or in combination with azithromycin for pneumonia associated with COVID-19 were found to be at increased risk for corrected QT interval prolongation.

A study from Italy reports severe outcomes related to the COVID-19 infection in patients with chronic plaque psoriasis receiving immunosuppressive therapies.

Hospitals have to remain current on how best to care for people with suspected or confirmed COVID-19 and educate these patients on appropriate discharge practices.

The most common comorbidities among patients hospitalized with COVID-19 in the New York City area are hypertension, obesity, and diabetes.

Individuals with novel coronavirus disease 2019 who have familial hypercholesterolemia may be at higher risk for cardiac complications and atherosclerotic cardiovascular disease in the long-term.